8-K - MACROGENICS INC (0001125345) (Filer)
Published . Updated .
Key takeaways
- 8-K - MACROGENICS filed an 8-K with the SEC on Nov 12 (a notice of a material company event).
- Exposed: MGNX
- Market reaction: MGNX −5.9% on the day (still updating)
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - MACROGENICS filed an 8-K with the SEC on Nov 12 (a notice of a material company event).
Directly affected
- MGNX Macrogenics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that MacroGenics belongs to, so it often moves with news about it.
- LLY Eli Lilly and
Eli Lilly and is a peer of MacroGenics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson
Johnson & Johnson is a peer of MacroGenics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie
AbbVie is a peer of MacroGenics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck
Merck is a peer of MacroGenics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories
Abbott Laboratories is a peer of MacroGenics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MGNX | +1.96% | +5.45% | base | -5.88% | after close | after close | after close |
| XLV | -1.60% | +0.57% | base | +0.19% | after close | after close | after close |
| LLY | -5.27% | +0.16% | base | +0.29% | after close | after close | after close |
| JNJ | -2.55% | -0.98% | base | +1.29% | after close | after close | after close |
| ABBV | -1.00% | -0.21% | base | +0.56% | after close | after close | after close |
| MRK | -0.13% | +0.71% | base | -0.28% | after close | after close | after close |
| ABT | +2.53% | +2.97% | base | +1.59% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-12 AccNo: 0001125345-26-000074 Size: 352 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Macrogenics (MGNX) since “8-K - MACROGENICS INC (0001125345) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +0.56% | still updating |
| ABBV | three days earlier | -0.21% | final price |
| ABBV | five days earlier | -1.00% | final price |
| ABT | that day | +1.59% | still updating |
| ABT | three days earlier | +2.97% | final price |
| ABT | five days earlier | +2.53% | final price |
| JNJ | that day | +1.29% | still updating |
| JNJ | three days earlier | -0.98% | final price |
| JNJ | five days earlier | -2.55% | final price |
| LLY | that day | +0.29% | still updating |
| LLY | three days earlier | +0.16% | final price |
| LLY | five days earlier | -5.27% | final price |
| Macrogenics (MGNX) | that day | -5.88% | still updating |
| Macrogenics (MGNX) | three days earlier | +5.45% | final price |
| Macrogenics (MGNX) | five days earlier | +1.96% | final price |
| MRK | that day | -0.28% | still updating |
| MRK | three days earlier | +0.71% | final price |
| MRK | five days earlier | -0.13% | final price |
| XLV | that day | +0.19% | still updating |
| XLV | three days earlier | +0.57% | final price |
| XLV | five days earlier | -1.60% | final price |
Congressional trades in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 23 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 69 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 36 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 43 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 48 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 36 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 59 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 69 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 49 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 85 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 36 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 41 days before publication. Filed 27 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Macrogenics (MGNX)
Companies tied to this story
- MGNX Macrogenics
For “8-K - MACROGENICS INC (0001125345) (Filer),” Macrogenics (MGNX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MGNX
How “8-K - MACROGENICS INC (0001125345) (Filer)” reaches Macrogenics (MGNX)
On 12 Nov 2026, “8-K - MACROGENICS INC (0001125345) (Filer)” is the story that connects Macrogenics (MGNX) to this story.
Macrogenics (MGNX) is on the page because SEC 8-K filing -> direct issuer disclosure -> MGNX
Dates and price levels for Macrogenics (MGNX)
MGNX traded between 1.93 and 3.74 across 17 sessions. The latest close on file is 2.29.
What the saved facts support for Macrogenics (MGNX)
14 out of 100Price not final
“8-K - MACROGENICS INC (0001125345) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.